{"id":476412,"date":"2020-03-26T13:34:01","date_gmt":"2020-03-26T13:34:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=476412"},"modified":"2020-03-26T13:34:01","modified_gmt":"2020-03-26T13:34:01","slug":"sanfilippo-syndrome-epidemiology-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sanfilippo-syndrome-epidemiology-forecast-to-2030_476412.html","title":{"rendered":"Sanfilippo Syndrome Epidemiology Forecast to 2030"},"content":{"rendered":"
\"Sanfilippo<\/a><\/p>\n
\n
Sanfilippo Syndrome Epidemiology<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s \u201cSanfilippo Syndrome Epidemiology Forecast to 2030\u201d report delivers an in-depth understanding of the disease, historical and forecasted Sanfilippo Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/div>\n

DelveInsight launched a new report on Sanfilippo Syndrome Epidemiology Forecast to 2030<\/p>\n

Some of the key facts of the report:-<\/strong><\/p>\n

    \n
  1. One in 70,000 children is born with <\/strong>Sanfilippo Syndrome, which is caused by an enzyme deficiency.  <\/strong><\/li>\n
  2. Sanfilippo Syndrome or Mucopolysaccharidosis type III (MPS III), has been classified as a rare disease with an incidence reported to be between 0.28 and 4.1 cases per 100,000 births.<\/strong><\/li>\n
  3. MPS III A is the most common subtype that affects around 1 in 100,000 births. <\/strong><\/li>\n<\/ol>\n

     <\/strong><\/p>\n

    Request for sample pages:- https:\/\/www.delveinsight.com\/sample-request\/sanfilippo-syndrome-epidemiology-forecast<\/a><\/p>\n

     \"\"<\/strong><\/p>\n

    Scope of the Report<\/strong><\/p>\n